Last reviewed · How we verify
no antibiotic prophylaxis
At a glance
| Generic name | no antibiotic prophylaxis |
|---|---|
| Sponsor | Shanghai Zhongshan Hospital |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Diarrhoea
- Nausea
- Febrile neutropenia
- Vomiting
- Fatigue
- Mucosal inflammation
- Decreased appetite
- Oedema peripheral
- Headache
- Pyrexia
- Stomatitis
- Abdominal pain
Key clinical trials
- Feasibility Study of Ocular Surface Squamous Neoplasia Surgical Excision in People Living With HIV in Sub-Saharan Africa (NA)
- SHAPE Pilot Trial: Skin Health and Allergy Prevention Exposure (NA)
- Polyurethane Foam Versus Gauze Dressing After Cesarean Delivery in a Standardized Surgical Setting: A Prospective Randomized Controlled Trial (NA)
- Prophylaxis Against Surgical Site Infections Using Local as Well as Systemic Antibiotic (NA)
- A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation (PHASE2)
- Evaluation of the Outcome of Fecal Microbiota Transplantation (PHASE1, PHASE2)
- Eradication of Helicobacter Pylori Subtypes at High Gastric Cancer Risk: a Cluster-randomized Controlled Trial (NA)
- Anthrax AV7909 Boost Evaluation Study (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- no antibiotic prophylaxis CI brief — competitive landscape report
- no antibiotic prophylaxis updates RSS · CI watch RSS
- Shanghai Zhongshan Hospital portfolio CI